| |
| |
|
| Insider
Information: |
Edelman Joseph |
| Relationship: |
Former 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
42 |
|
| Direct
Shares |
630,171 |
|
|
Indirect Shares
|
332,164,708 |
|
|
| Direct
Value |
$1,451,351 |
|
|
|
Indirect Value
|
$2,860,681,280 |
|
|
| Total
Shares |
332,794,879 |
|
|
| Total
Value |
$2,862,132,631 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
79
|
21
|
|
Stock
price went up :
|
50
|
11
|
| Stock
price went down : |
29
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
1.7
|
1.1
|
| Percentage
Gain/Loss : |
 13.4%
|
197.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2008-06-23 |
0 |
2008-06-23 |
6,387,546 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
10% Owner |
|
0 |
2011-11-02 |
0 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
10% Owner |
2012-11-01 |
133,133 |
2012-11-29 |
2,595,293 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
|
0 |
2017-06-19 |
4,533,728 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
|
0 |
2018-10-03 |
20,724,424 |
Premium* |
|
|
VBI Vaccines Inc |
VBIV |
10% Owner |
|
0 |
2014-07-25 |
2,610,356 |
Premium* |
|
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
|
0 |
2024-04-05 |
9,275,851 |
Premium* |
|
|
Aravive Inc |
ARAV |
10% Owner |
|
0 |
2017-09-22 |
2,099,563 |
Premium* |
|
|
Kadmon Holdings, Llc |
KDMN |
10% Owner |
|
0 |
2019-11-18 |
14,636,334 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2017-09-29 |
0 |
2018-08-10 |
4,070,357 |
Premium* |
|
|
Global Blood Therapeutics, Inc. |
GBT |
10% Owner |
2017-12-19 |
0 |
2017-12-19 |
4,889,066 |
Premium* |
|
|
Corium International, Inc. |
CORI |
10% Owner |
2018-01-16 |
0 |
2018-10-12 |
2,724,686 |
Premium* |
|
|
Albireo Pharma Inc |
ALBO |
10% Owner |
2018-01-25 |
0 |
2022-10-13 |
1,939,723 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
2018-01-30 |
0 |
2024-01-11 |
6,906,646 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
10% Owner |
2018-02-13 |
0 |
2019-01-08 |
2,253,376 |
Premium* |
|
|
Motus Gi Holdings Inc |
MOTS |
10% Owner |
2018-02-16 |
0 |
2021-01-22 |
2,660,542 |
Premium* |
|
|
Quotient Ltd |
QTNTQ |
10% Owner |
2018-05-22 |
0 |
2022-10-31 |
7,945,211 |
Premium* |
|
|
Dova Pharmaceuticals, Inc. |
DOVA |
10% Owner |
2018-06-04 |
0 |
2019-11-12 |
0 |
Premium* |
|
|
Meiragtx Holdings Plc |
MGTX |
10% Owner |
2018-06-08 |
0 |
2023-05-05 |
11,281,103 |
Premium* |
|
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
10% Owner |
2018-07-20 |
0 |
2022-04-18 |
5,321,032 |
Premium* |
|
|
Agile Therapeutics Inc |
AGRX |
10% Owner |
2018-07-26 |
0 |
2021-10-13 |
21,654,485 |
Premium* |
|
|
Verrica Pharmaceuticals Inc. |
VRCA |
10% Owner |
2018-06-19 |
0 |
2023-12-29 |
7,099,182 |
Premium* |
|
|
Athenex, Inc. |
ATNX |
10% Owner |
2019-05-06 |
0 |
2020-09-14 |
13,532,467 |
Premium* |
|
|
ADMA Biologics Inc |
ADMA |
10% Owner |
2019-05-21 |
0 |
2021-09-30 |
13,262,375 |
Premium* |
|
|
Foamix Pharmaceuticals Ltd |
FOMX |
10% Owner |
|
0 |
2019-07-29 |
11,203,881 |
Premium* |
|
|
Lyra Therapeutics, Inc. |
LYRA |
Director, 10% Owner |
2020-05-05 |
0 |
2023-05-31 |
12,757,563 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
10% Owner |
2020-06-09 |
0 |
2021-08-16 |
4,935,057 |
Premium* |
|
|
Leap Therapeutics, Inc. |
LPTX |
10% Owner |
2020-06-22 |
0 |
2020-06-22 |
8,476,496 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
Director, 10% Owner |
|
0 |
2023-12-29 |
5,402,964 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2020-10-20 |
0 |
2024-02-20 |
10,794,876 |
Premium* |
|
|
Scynexis Inc |
SCYX |
10% Owner |
2021-01-20 |
0 |
2021-01-22 |
1,800,000 |
Premium* |
|
|
Landos Biopharma, Inc. |
LABP |
Director, 10% Owner |
|
0 |
2021-02-09 |
17,960,839 |
Premium* |
|
|
Astria Therapeutics, Inc |
ATXS |
Director |
|
0 |
2024-02-01 |
6,485,420 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
3,314,032 |
Premium* |
|
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2021-04-27 |
0 |
2021-10-12 |
2,487,019 |
Premium* |
|
|
Nautilus Biotechnology, Inc |
NAUT |
10% Owner |
2021-05-24 |
497,038 |
2021-12-08 |
9,111,151 |
Premium* |
|
|
Isoplexis Corp |
ISO |
10% Owner |
2021-10-12 |
0 |
2021-10-12 |
3,554,587 |
Premium* |
|
|
Lianbio |
LIAN |
Director, 10% Owner |
|
0 |
2024-02-15 |
57,575,533 |
Premium* |
|
|
Acrivon Therapeutics, Inc. |
ACRV |
10% Owner |
|
0 |
2024-04-11 |
5,360,858 |
Premium* |
|
|
Chembio Diagnostics Inc |
CEMI |
Former 10% Owner |
2023-04-04 |
0 |
2023-04-27 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
10% Owner |
|
0 |
2023-06-06 |
2,207,753 |
Premium* |
|
|
Cargo Therapeutics, Inc. |
CRGX |
Former 10% Owner |
2023-11-14 |
0 |
2023-11-14 |
333,333 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
304 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CEMI |
Chembio Diagnostics Inc |
10% Owner |
– – • |
2023-04-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,672,662 |
|
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2023-05-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,864,455 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
10% Owner |
– – • |
2011-11-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,340,000) |
0 |
0 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
10% Owner |
– – • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
I/I |
256,386 |
1,800,541 |
0 |
- |
|
| VRCA |
Verrica Pharmaceuticals I... |
10% Owner |
– – • |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
I/I |
2,410,412 |
2,410,412 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,880,305 |
1,880,305 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2018-07-20 |
4/A |
A |
$0.00 |
$0 |
I/I |
1,880,305 |
2,187,953 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
10% Owner |
– – • |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,125,851) |
0 |
0 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
Director |
– • • |
2020-05-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,376,082 |
1,244,066 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Director |
– • • |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,644,785 |
2,055,981 |
0 |
- |
|
| LABP |
Landos Biopharma, Inc. |
Director |
– • • |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
13,369,728 |
1,770,600 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
10% Owner |
– – • |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,464,032 |
2,464,032 |
0 |
- |
|
| RAIN |
Rain Therapeutics Inc. |
10% Owner |
– – • |
2021-04-27 |
4 |
A |
$0.00 |
$0 |
I/I |
1,987,019 |
1,987,019 |
0 |
- |
|
| NAUT |
Nautilus Biotechnology, I... |
Former Director |
– – – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,914,113 |
8,911,151 |
0 |
- |
|
| ISO |
Isoplexis Corp |
10% Owner |
– – • |
2021-10-12 |
4 |
A |
$0.00 |
$0 |
I/I |
3,245,498 |
204,949 |
0 |
- |
|
| LIAN |
Lianbio |
10% Owner |
– – • |
2021-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
38,354,515 |
2,477,005 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • • |
2022-12-02 |
4 |
A |
$0.00 |
$15,249,996 |
I/I |
2,601,763 |
73,107 |
0 |
- |
|
| CRGX |
Cargo Therapeutics, Inc. |
Former 10% Owner |
– – – |
2023-11-14 |
4 |
A |
$0.00 |
$0 |
I/I |
2,579,502 |
2,579,502 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
Director |
– • – |
2024-02-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
170,317 |
0 |
0 |
- |
|
| QTNTQ |
Quotient Ltd |
10% Owner |
– – • |
2022-10-31 |
4 |
S |
$0.08 |
$660,449 |
I/I |
(8,255,607) |
7,945,211 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Former 10% Owner |
– – – |
2018-07-26 |
4 |
S |
$0.30 |
$89,439 |
I/I |
(298,628) |
3,231,372 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
10% Owner |
– – • |
2019-10-29 |
4 |
S |
$0.44 |
$334,528 |
I/I |
(760,291) |
6,151,110 |
0 |
- |
|
| CEMI |
Chembio Diagnostics Inc |
10% Owner |
– – • |
2023-04-04 |
4 |
B |
$0.44 |
$86,213 |
I/I |
195,938 |
3,868,600 |
1.5 |
% |
|
| CEMI |
Chembio Diagnostics Inc |
10% Owner |
– – • |
2023-04-06 |
4 |
B |
$0.44 |
$149,160 |
I/I |
339,000 |
4,425,100 |
1.5 |
% |
|
| CEMI |
Chembio Diagnostics Inc |
10% Owner |
– – • |
2023-04-11 |
4 |
B |
$0.44 |
$56,760 |
I/I |
129,000 |
4,554,100 |
1.5 |
% |
|
304 Records found
|
|
Page 2 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
